In Absence Of AMP Rules From CMS, Manufacturers Make Their Own

Drug manufacturers have been submitting average manufacturer price data to CMS using a new definition of AMP established by the Affordable Care Act. But they have been on their own when it comes to interpreting how to apply ACA to their calculation of AMP.

More from Archive

More from Pink Sheet